These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
122 related articles for article (PubMed ID: 25715900)
1. Incidence, management, and outcome of high-grade transformation of nodular lymphocyte predominant Hodgkin lymphoma: long-term outcomes from a 30-year experience. Eyre TA; Gatter K; Collins GP; Hall GW; Watson C; Hatton CS Am J Hematol; 2015 Jun; 90(6):E103-10. PubMed ID: 25715900 [TBL] [Abstract][Full Text] [Related]
2. Nodular, lymphocyte-predominant Hodgkin lymphoma: a long-term study and analysis of transformation to diffuse large B-cell lymphoma in a cohort of 164 patients from the Adult Lymphoma Study Group. Biasoli I; Stamatoullas A; Meignin V; Delmer A; Reman O; Morschhauser F; Coiffier B; Bosly A; Diviné M; Brice P Cancer; 2010 Feb; 116(3):631-9. PubMed ID: 20029973 [TBL] [Abstract][Full Text] [Related]
3. Transformation to aggressive lymphoma in nodular lymphocyte-predominant Hodgkin's lymphoma. Al-Mansour M; Connors JM; Gascoyne RD; Skinnider B; Savage KJ J Clin Oncol; 2010 Feb; 28(5):793-9. PubMed ID: 20048177 [TBL] [Abstract][Full Text] [Related]
4. Low nonrelapse mortality and prolonged long-term survival after reduced-intensity allogeneic stem cell transplantation for relapsed or refractory diffuse large B cell lymphoma: report of the Société Française de Greffe de Moelle et de Thérapie Cellulaire. Sirvent A; Dhedin N; Michallet M; Mounier N; Faucher C; Yakoub-Agha I; Mohty M; Robin M; Tabrizi R; Clement L; Bilger K; Larosa F; Contentin N; Huyn A; François S; Bulabois CE; Ceballos P; Bourrhis JH; Buzyn A; Cornillon J; Guillerm G; de Revel T; Bay JO; Guilhot F; Milpied N Biol Blood Marrow Transplant; 2010 Jan; 16(1):78-85. PubMed ID: 19744569 [TBL] [Abstract][Full Text] [Related]
5. A 20-year population-based study on the epidemiology, clinical features, treatment, and outcome of nodular lymphocyte predominant Hodgkin lymphoma. Strobbe L; Valke LL; Diets IJ; van den Brand M; Aben K; Raemaekers JM; Hebeda KM; van Krieken JH Ann Hematol; 2016 Feb; 95(3):417-23. PubMed ID: 26732883 [TBL] [Abstract][Full Text] [Related]
6. Management of nodular lymphocyte predominant Hodgkin lymphoma in the modern era. King MT; Donaldson SS; Link MP; Natkunam Y; Advani RH; Hoppe RT Int J Radiat Oncol Biol Phys; 2015 May; 92(1):67-75. PubMed ID: 25863755 [TBL] [Abstract][Full Text] [Related]
7. Lymphoma recurrence 5 years or later following diffuse large B-cell lymphoma: clinical characteristics and outcome. Larouche JF; Berger F; Chassagne-Clément C; Ffrench M; Callet-Bauchu E; Sebban C; Ghesquières H; Broussais-Guillaumot F; Salles G; Coiffier B J Clin Oncol; 2010 Apr; 28(12):2094-100. PubMed ID: 20308668 [TBL] [Abstract][Full Text] [Related]
8. Diffuse large B-cell lymphoma arising in nodular lymphocyte predominant Hodgkin lymphoma: a report of 21 cases from the Nebraska Lymphoma Study Group. Huang JZ; Weisenburger DD; Vose JM; Greiner TC; Aoun P; Chan WC; Lynch JC; Bierman PJ; Armitage JO Leuk Lymphoma; 2004 Aug; 45(8):1551-7. PubMed ID: 15370206 [TBL] [Abstract][Full Text] [Related]
9. Diffuse large B-cell lymphoma arising in nodular lymphocyte predominant hodgkin lymphoma. A report of 21 cases from the Nebraska Lymphoma Study Group. Huang JZ; Weisenburger DD; Vose JM; Greiner TC; Aoun P; Chan WC; Lynch JC; Bierman PJ; Armitage JO; Leuk Lymphoma; 2003 Nov; 44(11):1903-10. PubMed ID: 14738141 [TBL] [Abstract][Full Text] [Related]
10. Mature results of a phase II study of rituximab therapy for nodular lymphocyte-predominant Hodgkin lymphoma. Advani RH; Horning SJ; Hoppe RT; Daadi S; Allen J; Natkunam Y; Bartlett NL J Clin Oncol; 2014 Mar; 32(9):912-8. PubMed ID: 24516013 [TBL] [Abstract][Full Text] [Related]
11. Comparison of outcomes after allogeneic hematopoietic stem cell transplantation in patients with follicular lymphoma, diffuse large B-cell lymphoma associated with follicular lymphoma, or de novo diffuse large B-cell lymphoma. Tada K; Kim SW; Asakura Y; Hiramoto N; Yakushijin K; Kurosawa S; Tajima K; Mori S; Heike Y; Tanosaki R; Maeshima AM; Taniguchi H; Furuta K; Kagami Y; Matsuno Y; Tobinai K; Takaue Y; Fukuda T Am J Hematol; 2012 Aug; 87(8):770-5. PubMed ID: 22641292 [TBL] [Abstract][Full Text] [Related]
12. Diffuse large B cell lymphoma derived from nodular lymphocyte predominant Hodgkin lymphoma presents with variable histopathology. Hartmann S; Eray M; Döring C; Lehtinen T; Brunnberg U; Kujala P; Vornanen M; Hansmann ML BMC Cancer; 2014 May; 14():332. PubMed ID: 24885870 [TBL] [Abstract][Full Text] [Related]
13. Nodular lymphocyte predominant Hodgkin lymphoma: a Lymphoma Study Association retrospective study. Lazarovici J; Dartigues P; Brice P; Obéric L; Gaillard I; Hunault-Berger M; Broussais-Guillaumot F; Gyan E; Bologna S; Nicolas-Virelizier E; Touati M; Casasnovas O; Delarue R; Orsini-Piocelle F; Stamatoullas A; Gabarre J; Fornecker LM; Gastinne T; Peyrade F; Roland V; Bachy E; André M; Mounier N; Fermé C Haematologica; 2015 Dec; 100(12):1579-86. PubMed ID: 26430172 [TBL] [Abstract][Full Text] [Related]
14. Characteristics and outcomes of patients with nodular lymphocyte-predominant Hodgkin lymphoma versus those with classical Hodgkin lymphoma: a population-based analysis. Gerber NK; Atoria CL; Elkin EB; Yahalom J Int J Radiat Oncol Biol Phys; 2015 May; 92(1):76-83. PubMed ID: 25863756 [TBL] [Abstract][Full Text] [Related]
15. Autologous bone marrow transplantation after histologic transformation of indolent B cell malignancies. Friedberg JW; Neuberg D; Gribben JG; Mauch P; Anderson KC; Soiffer RJ; Takvorian T; Fisher DC; Schlossman R; Jallow H; Kuhlman C; Ritz J; Freedman AS Biol Blood Marrow Transplant; 1999; 5(4):262-8. PubMed ID: 10465106 [TBL] [Abstract][Full Text] [Related]
19. Nodular lymphocyte predominant Hodgkin lymphoma and diffuse large B-cell lymphoma: a study of six cases concurrently involving the same site. Cotta CV; Coleman JF; Li S; Hsi ED Histopathology; 2011 Dec; 59(6):1194-203. PubMed ID: 22175899 [TBL] [Abstract][Full Text] [Related]
20. Race-specific features and outcomes of nodular lymphocyte-predominant Hodgkin lymphoma: Analysis of the National Cancer Data Base. Olszewski AJ; Shrestha R; Cook NM Cancer; 2015 Oct; 121(19):3472-80. PubMed ID: 26149294 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]